Embolization is a minimally invasive procedure that plugs one or more blood arteries or aberrant vascular channels as an alternative to open surgery. Blood vessels can be blocked using embolization techniques instead of invasive surgery. Embolization is a procedure that can be used to halt arterial bleeding as well as to block blood arteries for various purposes, including the treatment of malignancies, flow redirection, and the reduction of vascular abnormalities, among others. In interventional radiology, embolization is a fairly common and efficient technique. Vascular embolization agents are used to mechanically occlude blood vessels or other vascular areas to cease flow. Vascular embolization agents have a high success rate, a sparse use of general anaesthetics, a quicker recovery period, a low risk of infection, and no scarring.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5150
The market for vascular embolization was valued at US$ 1,509.1 Mn in 2021 and is expected to expand at a CAGR of 9.5% between 2022 and 2028 attending US$ 2,851.5 Mn.
In terms of volume, North America maintained the top spot in the global market for vascular embolization in 2020, with a 41.2% share, followed by Europe and Asia Pacific.
Cook Medical introduced the Approach Authority 0.018 diameter Workhorse Microwire Guide in February 2021 in Canada and the United States. It is designed to be utilised for multiple purposes while undergoing the same treatment and is used to put balloon dilation catheters undergoing percutaneous transluminal angioplasty.
Wright Medical, a multinational business that specializes in extremities and biologics that manufactures medical equipment, was acquired by Stryker in November 2020.
Following clearance in the United States, Stryker announced the introduction of the Surpass Evolve flow diverter in August 2020, which is suggested in cases of brain aneurysms.
The worldwide market for vascular embolization will expand over the forecast period because to the rising incidence of vascular disorders everywhere. Any disorder that compromises the blood vessel network is referred to as a vascular disease. They are widespread and may be dangerous. The World Health Organization (WHO), claims that cardiovascular diseases (CVDs), s estimated 17.9 million lives annually, are the leading cause of mortality worldwide. This accounts for 35% of all fatalities worldwide.
Over the course of the projection period, improvements in embolization products and methods will accelerate market expansion. The AZUR Vascular Plug was announced in July 2021 by Terumo Medical Corporation as the first plug that may be used with a micro-catheter to seal arteries up to 8mm in diameter. It is recommended to employ the newest addition to Terumo’s extensive embolization portfolio to slow down or stop blood flow via the arteries in the peripheral vasculature.
The development of the worldwide vascular embolization market is anticipated to be hampered by complications related to embolization operations. An embolic agent may accidentally lodge in the incorrect location, denying normal tissue of its oxygen supply. Even if an antibiotic has been administered, there is always a chance of infection following embolization. Fever, discomfort in the right hypochondrium (area of the abdomen), and an increase in transaminases are problems that might occur in patients with liver cancer who are receiving embolism treatment.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5150
The development of the worldwide vascular embolization market is anticipated to be constrained by the high cost of embolization operations. Despite the procedure’s many advantages, it is pricey, especially for patients in rich and developing nations who are in need. Vascular diseases are becoming more commonplace on a global scale. However, access to these facilities is restricted in poor and disadvantaged nations due to the greater prices of treatments.
The desire for less invasive procedures is predicted to increase, offering industry participants considerable development prospects. The American College of Cardiology estimates that in 2020, around 1.2 million angioplasties were carried out annually in the United States. In addition, hospitals are likely to draw a sizable patient base because to their greater accessibility and cost than speciality clinics.
The market’s participants should benefit from attractive growth prospects as the need for innovative therapies rises. Terumo Corporation unveiled the WEB Embolization System which is an intrasaccular aneurysm therapy device, in December 2020 in Japan in an effort to provide patients with brain aneurysms who were difficult to treat with conventional methods with new treatment options. It is an intrasaccular flow disruptor device that is only accessible in Japan.
Market Trends/Key Takeaways
The global market for vascular embolization is anticipated to develop as a result of an increase in clot agent usage. For instance, Johnson & Johnson Medical Devices Companies’ Cerenovus announced the launch of CERENOVUS NIMBUS in Europe in October 2020. This device is intended to dissolve stubborn clots for effective revascularization in patients with acute ischemic stroke brought on by a major artery obstruction. The Cerenovus Nimbus is made to dissolve abrasive clots.
The rise in traffic accidents throughout the world is anticipated to fuel market expansion for vascular embolization. Embolization plays a crucial role in the non-operative care of many severe injuries, providing expedited/minimally invasive control of bleeding with less damage of normal tissues than surgery, leading to a lower need for blood transfusion and enhanced survival. According to the WHO, road traffic accidents account for almost 1.3 million annual fatalities, making them the top cause of mortality worldwide.
Includes Shape Memory Medical Inc., Medtronic PLC, Terumo Corp, Cook Medical, Penumbra Inc., Stryker Corporation, Merit Medical Systems Inc., Boston Scientific Corporation, Johnson and Johnson (Cerenovus), and Abbott Laboratories.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5150
Reasons to buy this Vascular Embolization Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Vascular Embolization market size estimation and recent advancements in the industry are explained.
The Study Objectives are:
✔ A comprehensive insight into key players operating in the Vascular Embolization Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Vascular Embolization Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Vascular Embolization Industry Impact
Chapter 2 Global Vascular Embolization Competition by Types, Applications, and Top Regions and Countries
2.1 Global Vascular Embolization (Volume and Value) by Type
2.3 Global Vascular Embolization (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Vascular Embolization Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Vascular Embolization Market Analysis
Chapter 6 East Asia Vascular Embolization Market Analysis
Chapter 7 Europe Vascular Embolization Market Analysis
Chapter 8 South Asia Vascular Embolization Market Analysis
Chapter 9 Southeast Asia Vascular Embolization Market Analysis
Chapter 10 Middle East Vascular Embolization Market Analysis
Chapter 11 Africa Vascular Embolization Market Analysis
Chapter 12 Oceania Vascular Embolization Market Analysis
Chapter 13 South America Vascular Embolization Market Analysis
Chapter 14 Company Profiles and Key Figures in Vascular Embolization Business
Chapter 15 Global Vascular Embolization Market Forecast (2022-2028)
Chapter 16 Conclusions
Customization of the Report
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027